ArticleAntimicrobial agents and chemotherapy2026

Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin.

Keith A Rodvold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.